2021
DOI: 10.1016/j.copsyc.2020.05.006
|View full text |Cite
|
Sign up to set email alerts
|

General psychiatric management for adolescents (GPM-A) with borderline personality disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 40 publications
0
9
0
Order By: Relevance
“…At the present time, no medications are approved by the U.S. Food and Drug Administration for the treatment of BPD, regardless of age, and there is a dearth of information concerning pharmacotherapy for this condition in youth. [9][10][11] Education on BPD was provided to the patient and parents. The reported hallucinations were put in the context of a "stress" response and were not considered to be related to schizophrenia.…”
Section: Case Descriptionmentioning
confidence: 99%
See 1 more Smart Citation
“…At the present time, no medications are approved by the U.S. Food and Drug Administration for the treatment of BPD, regardless of age, and there is a dearth of information concerning pharmacotherapy for this condition in youth. [9][10][11] Education on BPD was provided to the patient and parents. The reported hallucinations were put in the context of a "stress" response and were not considered to be related to schizophrenia.…”
Section: Case Descriptionmentioning
confidence: 99%
“…The patient was safely tapered off all medications without a change in her mental status or functioning. At the present time, no medications are approved by the U.S. Food and Drug Administration for the treatment of BPD, regardless of age, and there is a dearth of information concerning pharmacotherapy for this condition in youth 9–11 . Education on BPD was provided to the patient and parents.…”
Section: Case Descriptionmentioning
confidence: 99%
“…DBT studies with adolescents have demonstrated it can significantly reduce suicide risk in most patients (Canadian Agency for Drugs and Technologies in Health, 2010; Linehan et al, 2015; McCauley et al, 2018). Other evidence-based treatments include mentalization based therapy (Griffiths et al, 2019), Transference-focussed psychotherapy (Normandin et al, 2021) and General Psychiatric Management for adolescents (Ilagan and Choi-Kain, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Besides DBT-A, there are other age-adapted versions of most psychotherapeutic approaches for the treatment of BPD (Chanen et al, 2008; Foelsch et al, 2014; Ilagan & Choi-Kain, 2021; Rossouw & Fonagy, 2012; Schuppert et al, 2012). Although RCTs have been conducted for some of these (cognitive analytic therapy [CAT]: Chanen et al, 2008; mentalization-based therapy for adolescents: Rossouw & Fonagy, 2012; emotion regulation therapy: Schuppert et al, 2012; mentalization-based group therapy: Jørgensen et al, 2021), the empirical evidence for the efficacy of disorder-specific psychotherapy in adolescent BPD is still insufficient (Storebø et al, 2020; Wong et al, 2020).…”
mentioning
confidence: 99%